FindTrial
Sign In

Dopamine neurotransmission and internet addiction

Dopamine neurotransmission and internet addiction - Dopamine neurotransmission and internet addiction

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000007240
Enrollment
20
Registered
2012-02-09
Start date
2012-02-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dopamine neurotransmission and internet addiction

Interventions

Intravenous injection of [11C]SCH23390 and [11C]raclopride

Sponsors

National Institute of Radiological Sciences
Lead Sponsor

Eligibility

Sex/Gender
Male

Inclusion criteria

Inclusion criteria: No current or history of psychiatric disorders and absence of severe somatic diseases. Ability to understand an explanation document and give consent.

Exclusion criteria

Exclusion criteria: Presence of severe diseases and currently undergoing treatment for them. Participation in the other studies involving the use of nuclear medicine within 6 months. Judged inappropriate as a subject by the investigators.

Design outcomes

Primary

MeasureTime frame
The association between dopamine receptor densities and psychological measures related to internet addiction.—

Countries

Japan

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026